All In MedTech

Device Trial Radar · NCT01643525

Study to Test Sensitivity and Specificity of Passive Wave Pressure Device in Determining Ischemic Stroke

A NonRandomized, Multicenter, NonSig Risk Study With a NonInv, Passive PressureWave Method of Diagnosing Cerebral Anomalies to Develop a Diag. Algorithm for Cerebral Isch and to Test Sens./Spec. of This Algorithm in Determining Isch Stroke

Last checked: Nov 19, 2026Latest source record: Jul 8, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

29

Actual

Start

Jun 2012

Primary completion

Dec 2012

Study completion Dec 2012

Sponsor

Lead sponsor
Jan Medical, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jul 18, 2012

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years, up to 90 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

That the Jan Medical Nautilus NeuroWaveTM system provides significantly higher sensitivity to hyper acute ischemic stroke than does CT.

Conditions

  • Ischemic Stroke

Interventions

  • Nautilus NeuroWaveTM SystemDevice

    Non-invasive device designed to detect pressure signals from the skull to aid in the diagnosis of ischemic stroke.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Device Related Adverse EventsTime frame: 2-3 days, at subject exit (variation of subject exit date depended on when subject obtained their radiology imaging to confirm ischemic stroke)

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Johns Hopkins Hospital

    Baltimore, Maryland

  • Johns Hopkins Bayview Medical Center

    Baltimore, Maryland

  • Howard County General Hospital

    Columbia, Maryland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.